<?php
/**
 * Template Name: Monitoring
 *
 * @package understrap
 */

// get_header();

$container   = get_theme_mod( 'understrap_container_type' );
$sidebar_pos = get_theme_mod( 'understrap_sidebar_position' );

?>
<!DOCTYPE html>
<html>

    <?php include 'modules/header.php'; ?>
    
<body>

    <div class="body">

        <?php include 'modules/main-menu.php'; ?>

        <div role="main" class="main">

            <section class="page-header page-header-modern bg-color-light-scale-1 page-header-md ">
                <div class="container-fluid">
                    <div class="row align-items-center">
                        <div class="col">
                            <div class="row">
                                <div class="col-md-12 align-self-center p-static order-2 text-center">
                                    <div class="overflow-hidden pb-2">
                                        <h1 class="text-dark font-weight-bold text-9 appear-animation"
                                            data-appear-animation="maskUp" data-appear-animation-delay="100">Continual
                                            Review, Annual Recertification and Safety Monitoring</h2>
                                    </div>
                                </div>
                                <div class="col-md-12 align-self-center order-1">
        
                                    <ul class="breadcrumb d-block text-center">
                                        <li><a href="/home">Home</a></li>
                                        <li class="active">Continual
                                            Review, Annual Recertification and Safety Monitoring</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
            </section>

            <div class="container py-4 mb-4">

                <div class="row">
                    <div class="col-lg-9">

                        <div class="row">
                            <div class="col">

                                <div class="lightbox"
                                    data-plugin-options="{'delegate': 'a.lightbox-portfolio', 'type': 'image', 'gallery': {'enabled': true}}">
                                    <div class="row portfolio-list">
                                        <div class="col-lg-12 appear-animation" data-appear-animation="fadeInUpShorter"
                                            data-appear-animation-delay="500">
                                            <div class="portfolio-item">
                                                <span
                                                    class="thumb-info thumb-info-centered-icons thumb-info-no-borders">
                                                    <span class="thumb-info-wrapper">
                                                        <img src="/wp-content/uploads/img/integrity/Continual-Review-Annual-Recertification-and-Safety-Monitoring.jpg" class="img-fluid" alt="">
                                                        <a href="/wp-content/uploads/img/integrity/Continual-Review-Annual-Recertification-and-Safety-Monitoring.jpg" class="lightbox-portfolio">
                                                            <span class="thumb-info-action">
                                                                <span
                                                                    class="thumb-info-action-icon thumb-info-action-icon-light"><i
                                                                        class="fas fa-search text-dark"></i></span>
                                                            </span>
                                                        </a>
                                                    </span>
                                                </span>
                                            </div>
                                        </div>
                                    </div>
                                </div>

                            </div>
                        </div>
                        <div class="row pt-4 mt-2 mb-5">
                            <div class="col-md-12 mb-4 mb-md-0">

                                <div class="overflow-hidden mb-2">
                                    <h2 class="text-color-dark font-weight-normal text-5 mb-0 appear-animation"
                                        data-appear-animation="maskUp"> <strong class="font-weight-extra-bold"></strong>
                                    </h2>
                                </div>

                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="200">All research approved by the IREC will be subject
                                    to substantive, meaningful and focused continuing review to determine that the risks
                                    and benefits of the study have not changed, that there are no unanticipated findings
                                    involving risks to participants and/or others, and that any new information
                                    regarding risks and benefits are provided to the participants. The review will occur
                                    every two years, unless the level of risk requires more frequent review. The IREC
                                    may withdraw approval of a protocol previously approved.</p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="400">
                                    All applications will be reviewed by the full committee. However, the final decision
                                    rests with the Chairperson or a person delegated with this responsibility. At least
                                    one member of the IREC will receive a copy of the full protocol including any
                                    modifications that have been previously approved by the IREC, with the full
                                    committee having access to the complete IREC protocol file and relevant IREC minutes
                                    at the convened meeting. All studies will require continual review until the IREC
                                    receives the final study report and the completion of study form (appendix G).
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">All applications for continual review must be
                                    submitted by the primary investigator
                                    to the IREC on the IREC safety monitoring and annual recertification report form
                                    (appendix F) along with any other supporting documentation. This documentation will
                                    need to be sent to the IREC Administrator at least 14 days before the meeting to be
                                    added to the IREC meeting agenda and will be distributed to members for review. The
                                    IREC should receive this application at least three months before the ethics
                                    approval for the study expires; this will ensure that re-approval takes place before
                                    the studies ethical approval expires. No study may continue without valid ethical
                                    approval and re-certification. Once the IREC has assessed the continual review
                                    application the study may

                                <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <li>Continue as originally approved.</li>
                                    <li>Have some modifications.</li>
                                    <li>Request a site visit by the safety monitoring committee.</li>
                                    <li>Be suspended</li>
                                    <li>Be terminated</li>
                                </ul>
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                data-appear-animation-delay="600">
                                    The IREC Administrator will inform the principal investigator in writing of the
                                    outcome of their application and any reasons for its decision. All conditions
                                    required by the IREC must be met before continual approval will be granted. If the
                                    principal investigator appeals the decision, the IREC must ensure there is a fair
                                    hearing of the query.</p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Safety monitoring</strong><br>

                                    The IREC will monitor compliance with respect to the approved research protocol
                                    ensuring the protection of the research participants. Such continued monitoring
                                    allows for early intervention should proceedings deviate intentionally or
                                    unintentionally from the approved sequence of events<br />

                                    A Safety Monitoring Committee (SMC) will be formulated by the IREC and function as a
                                    sub-committee thereof. The role of the SMC is to perform the following functions:
                                <ol class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <li>
                                        Investigate and report on the following:
                                        <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                            data-appear-animation-delay="600">
                                            <li>Ascertain if an approved study is being conducted according to its
                                                approved protocol.</li>
                                            <li>Ascertain whether an approved study is being conducted according to
                                                the conditions of approval by the IREC.</li>
                                            <li>Ascertain whether amendments to the original protocol are necessary.
                                            </li>
                                        </ul>
                                    </li>
                                    <li>Monitor and report on the following
                                        <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                            data-appear-animation-delay="600">
                                            <li>Progress made in an approved study in respect of the anticipated
                                                timeframe as indicated in the proposal.</li>
                                            <li>Outcomes and findings of such approved studies upon completion
                                                thereof.</li>
                                        </ul>
                                    </li>
                                    <li>
                                        Review and investigate if required:
                                        <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                            data-appear-animation-delay="600">
                                            <li>All adverse events should they arise and advise the IREC
                                                accordingly.</li>
                                            <li>Report to the IREC the findings of the SMC with respect to each
                                                adverse event.</li>
                                        </ul>
                                    </li>
                                </ol>
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Composition of the SMC</strong><br>

                                    The SMC will comprise, at minimum, a member of the IREC and at least 2 additional
                                    people who meet the following criteria:<br />
                                <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                data-appear-animation-delay="600">
                                    <li>
                                        Suitable expertise and experience in the field of study to be reviewed.
                                    </li>
                                    <li>
                                        Neutrality with regard to the site, to the principal investigator, and to
                                        other relevant parties involved.
                                    </li>
                                </ul></p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                data-appear-animation-delay="600"> the absence of suitable expertise necessary, the IREC may source such
                                expertise from other academic institutions or from industry.
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Monitoring procedure</strong><br>Safety monitoring reports:<br>

                                    The principal investigator will submit a safety monitoring and recertification
                                    report form every two years (appendix F), along with any other supporting
                                    documentation, to the IREC, a minimum of three months before ethical approval of the
                                    study lapses. In situations where the IREC deems fit, additional safety monitoring
                                    reports may be requested. Such situations may include<br />
                                <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <li>
                                        Studies involving vulnerable population groups.
                                    </li>
                                    <li>
                                        Studies graded as Level 3 (possible risk/ risk to humans, animals,
                                        environment or sensitive/ highly sensitive research).
                                    </li>
                                    <li>Studies in which additional factors warrant more stringent monitoring e.g.
                                        sample size, complexity of design, location and number of trial sites,
                                        degree of financial outlay, number of investigators, degree of experience of
                                        the site and staff, degree of manpower involved OR other factors deemed to
                                        justify such additional monitoring by the IREC.</li>
                                    <li>Studies with sites from which complaints have been received.</li>
                                    <li>Studies suspected to be not complying with approved protocol.</li>
                                </ul></p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                data-appear-animation-delay="600">In the absence of suitable expertise necessary, the IREC may source such
                                expertise from other academic institutions or from industry.
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Site inspection</strong><br>

                                    In order to perform the first function, the SMC may conduct site inspections/audits
                                    on behalf of the IREC. Such site inspections may include inspections of the
                                    following:<br />
                                <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <li>
                                        The presence and suitability of all trial documentation and essential
                                        documents (appendix F).
                                    </li>
                                    <li>
                                        Appropriateness and suitability of facilities and infrastructure at the
                                        trial site.
                                    </li>
                                    <li>Suitability of expertise and staff recruited to participate in or facilitate
                                        the research process</li>
                                    <li>Investigational equipment for monitoring and interventions made.</li>
                                    <li>Investigational products and interventions with respect to storage,
                                        labelling, dispensing, counselling of participants, administration, stock
                                        control, and disposal thereof</li>
                                    <li>Administration and storage of all trial documentation.</li>
                                    <li>Evidence of recruitment strategy and practice applied (including informed
                                        consent).</li>
                                    <li>General evidence to support the degree of compliance with the approved
                                        research protocol.</li>
                                </ul>All studies categorised as Level 3 as defined in the proposal document, will be
                                subject to a minimum of one annual, compulsory site inspection by the SMC. All other
                                studies will be subject to site inspections as deemed fit by the IREC based on
                                random selection or based on the factors warranting greater than one annual safety
                                monitoring report.
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Progress monitoring:</strong><br>
                                    In order to perform the site inspection, the SMC may request progress reports from
                                    the principal investigator; such reports if necessary, may be required to be
                                    substantiated by the submission of additional evidence or by undertaking site
                                    inspections. Studies which do not meet the anticipated progress targets set in the
                                    approved protocol will be reported to the IREC for review and intervention.
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Investigation of adverse events:</strong><br>
                                    In order to perform progress monitoring, all Adverse Event Reports submitted to the
                                    IREC will be delegated to the SMC for investigation, corroboration and reporting.
                                    The SMC may request additional supporting evidence and documentation from the
                                    principal investigator, conduct an appropriate site inspection, or interview
                                    involved parties and stakeholders should it be warranted. Upon concluding its
                                    investigation, a report of the findings will be submitted to the IREC for review.
                                </p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <strong>Independent site/trial audit:</strong><br>
                                    The IREC may request an independent site audit should it be warranted; such an audit
                                    may be instituted in the following situations:
                                <ul class="appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="600">
                                    <li>Studies/sites in which significant evidence of non-compliance or
                                        transgression of research protocol exists.</li>
                                    <li>Studies/sites from which serious or multiple complaints have been received.
                                    </li>
                                    <li>Studies/sites from which serious adverse events or serious adverse drug
                                        reactions are reported.</li>
                                    <li>Studies/sites suspected of committing fraudulent acts.</li>
                                    <li>Studies/sites suspected serious of breach of confidentiality and or poor
                                        handling of participants.</li>
                                    <li>Any additional situations in which the IREC deems an independent audit
                                        necessary.</li>
                                </ul></p>
                                <p class="appear-animation" data-appear-animation="fadeInUpShorter"
                                data-appear-animation-delay="600">In such situations an independent suitably qualified auditor will be appointed
                                by the IREC to act on its behalf and conduct the audit, the aim being to determine
                                if the research is being conducted according to and in keeping with the approved
                                research protocol; that participants are protected and treated fairly and ethical
                                standards are maintained.<br>
                                <a href="https://www.dut.ac.za/wp-content/uploads/2012/06/APPENIDX-F-Safety-Monitoring-and-Annual-Recertification-Report1.docx"
                                    target="_blank">Safety Monitoring and Annual Recertification Report</a>
                                </p>

                                <hr class="solid my-5 appear-animation" data-appear-animation="fadeInUpShorter"
                                    data-appear-animation-delay="500">

                            </div>
                        </div>

                    </div>

                    <?php include 'modules/quick-links.php'; ?>

                </div>

            </div>

        </div>
        <?php include 'modules/footer.php'; ?>
    </div>

    <?php include 'modules/footer-script.php'; ?>

</body>

</html>